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Background: Proteins of the mammalian PYHIN (IFI200/HIN-200) family are involved in defence against infection
through recognition of foreign DNA. The family member absent in melanoma 2 (AIM2) binds cytosolic DNA via its
HIN domain and initiates inflammasome formation via its pyrin domain. AIM2 lies within a cluster of related genes,
many of which are uncharacterised in mouse. To better understand the evolution, orthology and function of these
genes, we have documented the range of PYHIN genes present in representative mammalian species, and
undertaken phylogenetic and expression analyses.
Results: No PYHIN genes are evident in non-mammals or monotremes, with a single member found in each of
three marsupial genomes. Placental mammals show variable family expansions, from one gene in cow to four in
human and 14 in mouse. A single HIN domain appears to have evolved in the common ancestor of marsupials and
placental mammals, and duplicated to give rise to three distinct forms (HIN-A, -B and -C) in the placental mammal
ancestor. Phylogenetic analyses showed that AIM2 HIN-C and pyrin domains clearly diverge from the rest of the
family, and it is the only PYHIN protein with orthology across many species. Interestingly, although AIM2 is
important in defence against some bacteria and viruses in mice, AIM2 is a pseudogene in cow, sheep, llama,
dolphin, dog and elephant. The other 13 mouse genes have arisen by duplication and rearrangement within the
lineage, which has allowed some diversification in expression patterns.
Conclusions: The role of AIM2 in forming the inflammasome is relatively well understood, but molecular
interactions of other PYHIN proteins involved in defence against foreign DNA remain to be defined. The non-AIM2
PYHIN protein sequences are very distinct from AIM2, suggesting they vary in effector mechanism in response to
foreign DNA, and may bind different DNA structures. The PYHIN family has highly varied gene composition
between mammalian species due to lineage-specific duplication and loss, which probably indicates different
adaptations for fighting infectious disease. Non-genomic DNA can indicate infection, or a mutagenic threat. We
hypothesise that defence of the genome against endogenous retroelements has been an additional evolutionary
driver for PYHIN proteins.
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Members of the PYHIN protein family have recently
come to prominence as receptors mediating the detec-
tion of foreign DNA and initiating innate immune
responses. Absent in melanoma 2 (AIM2) binds DNA in
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reproduction in any medium, provided the orthe inflammasome pathway [1-4]. A second family mem-
ber, p202, binds to cytosolic DNA and antagonises this
pathway [4]. The inflammasome is a protein complex
initiating activation of the protease precursor procaspase
1. Active caspase 1 cleaves proIL-1β and proIL-18 prior
to their secretion as active inflammatory cytokines, and
also leads to rapid lytic cell death termed “pyroptosis”
[5]. AIM2-mediated responses are elicited by viruses
such as mouse cytomegalovirus (MCMV) and vaccinia,
the cytosolic bacteria Francisella tularensis and Listeria
monocytogenes, and even extracellular bacteria such asl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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for effective control of Francisella tularensis and MCMV
infection of mice [6,7,11].
Another PYHIN family member, human IFI16, was
shown to mediate inflammasome responses to Kaposi’s
sarcoma virus DNA in the nucleus [12]. Infection led to
increased nuclear colocalisation of IFI16 with ASC, fol-
lowed by emigration of both factors into the perinuclear
region. IFI16 but not AIM2 knockdown decreased
procaspase-1 cleavage in response to viral infection. On
the other hand, IFI16 and mouse PYHIN protein p204
were found to play a role in the recognition of foreign
DNA leading to induction of interferon-β (IFN-β), which
is a pathway distinct from the inflammasome [13]. In-
duction of IFN-β by cytosolic DNA requires the adapter
protein STING (stimulator of interferon genes), and sub-
sequent activation of TANK-binding kinase 1 (TBK1)
leading to phosphorylation and nuclear translocation of
the transcription factor interferon regulatory factor-3
(IRF-3) [14-18]. IFI16 is not the only contender for such
a role in DNA recognition, as recent work suggests that
the unrelated helicase protein DDX41 is the DNA-
binding protein primarily required for the early induc-
tion of signalling leading to IFN-β production whilst
IFI16-mediated responses to DNA may prolong the in-
duction of IFN-β later in the response [19]. Both IFI16
and DDX41 were reported to bind to STING [13,19].
Overall, study of the PYHIN gene family has been ham-
pered by the complexity of the family in mouse, and a
lack of understanding of orthology between mouse and
human genes.
The PYHIN genes were identified as a cluster on
mouse and human chromosome 1 and were named
mouse Ifi200 (“interferon inducible”) [20,21] and human
HIN-200 (“hematopoietic, interferon-inducible nuclear
proteins with a 200 amino acid repeat”) [22]. They have
more recently been annotated as the “PYHIN” family, ac-
knowledging the defining features of an N-terminal
pyrin domain and C-terminal HIN domain. There are
four human PYHIN proteins: IFI16 (interferon inducible
protein 16) [23], MNDA (myeloid nuclear differentiation
antigen) [24], AIM2 [25] and IFIX (interferon inducible
protein X) [26]. Publications have so far detailed seven
mouse proteins p202(a/b), p203, p204, p205, p206,
Aim2/p210, and Mndal (MNDA-like) as well as a num-
ber of predicted proteins [22,27-30]. Family members
are predominantly nuclear proteins, some with defined
nuclear localisation signals [22]. There is potential for
regulated localisation, since acetylation of the nuclear lo-
calisation signal of IFI16 led to its cytosolic accumula-
tion [31]. Some family members have characterised
nuclear export sequences [32], suggesting they may shut-
tle in and out of the nucleus. In contrast, p202 and
AIM2 lack nuclear localisation signals and reside in thecytoplasm of untreated cells [2,4], consistent with the
role of AIM2 and p202 in the recognition of cytosolic
DNA. p206 is also reported to have cytoplasmic location
[27].
Prior to the finding that members of the family func-
tion in pathogen recognition, publications focused on
roles in cell growth and cell cycle control, tumour sup-
pression, apoptosis, DNA damage response, senescence,
muscle and myeloid differentiation and autoimmunity
[33-38]. These functions are comprehensively reviewed
elsewhere [22,39-42]. There is as yet limited insight into
the specific molecular roles of the proteins in these di-
verse functions. Various family members have been
found to bind tumour suppressors such as p53, BRCA1
(breast cancer 1, early onset) and retinoblastoma protein
[34,43-45], supportive of roles in cell cycle regulation,
DNA repair and apoptosis. Interactions with a range of
transcription factors and signalling molecules are also
reported [46-50]. The novel roles being uncovered for
PYHIN proteins in host defence now provide relevance
for the long-established interferon-inducibility of these
genes. Consistent with viral need to evade detection, sev-
eral viral proteins are characterised to bind PYHIN fam-
ily members [51-53].
The PYHIN proteins are defined by the possession of
one or two 200-amino acid HIN domains at the C
terminus, and a pyrin domain at the N terminus [22,40].
The roles of the HIN and pyrin domains are well estab-
lished for AIM2-mediated inflammasome responses
[1,2]. AIM2 recognises DNA via its HIN domain, and
then recruits the inflammasome adapter protein ASC
(apoptosis-associated speck-like protein containing a
CARD) via homotypic interaction of pyrin domains.
ASC itself recruits procaspase 1 via its caspase recruit-
ment domain (CARD), resulting in intermolecular cleav-
age to give active caspase 1. The pyrin domain of AIM2
can therefore be considered the effector domain eliciting
inflammasome formation. Pyrin domains (also known as
PYD, PAAD or DAPIN) are also found in other proteins
involved in inflammasome formation, such as NOD-like
receptors. They are part of the death domain superfam-
ily which also includes the death domain, death effector
domain, and CARD [54]. Death domains form six-helix
bundles and are frequently involved in recruitment of
proteins in apoptotic and inflammatory responses
through homotypic interactions.
The HIN domain is unique to the PYHIN family, and
three distinct sequence classes, HIN-A, -B, and -C, have
been defined [22]. The HIN domain was predicted to
combine two oligonucleotide/oligosaccharide binding
(OB)-folds [55]. OB-folds are five-stranded β-barrel
structures found in a number of single stranded DNA
(ssDNA)-binding proteins such as replication protein A
and breast cancer 2, early onset (BRCA2). The OB-fold
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the HIN domains of IFI16 and AIM2 [56,57]. The struc-
ture of double stranded (ds) DNA-bound proteins [56]
showed that interaction between the HIN domains and
DNA was primarily by electrostatic interaction with
the sugar-phosphate backbone, explaining the DNA
sequence-independent responses to cytosolic DNA. This
work also suggested that in the absence of DNA, the
pyrin domain is bound to the HIN domain in an autoin-
hibited state. Unterholzner et al. showed that the tan-
dem HIN domains of IFI16 were more effective in DNA
binding than its single HIN-B domain, with the HIN-A
domain alone being ineffective [13]. Interestingly, recent
work showed that IFI16 had a preference for binding
cruciform structure DNA [58]. Native mouse p202,
which also has two HIN domains, strictly bound to
dsDNA and not ssDNA [4], and biological responses
mediated via AIM2 are dependent on dsDNA, and are
not elicited by ssDNA [4]. Beyond this, whether the HIN
domains of different PYHIN family members have any
specificity for particular DNA sequences or structures
remains to be established.
The presence of four PYHIN family members in
human has been known for a number of years, but the
number of predicted mouse genes has increased with
each new release of the mouse genome. In this paper, we
describe the mouse, human and rat gene loci and pro-
teins, address the issue of orthology between mouse and
human genes and expression of the many mouse genes,
and examine the evolution of the gene family within
mammals. This provides a picture of a rapidly evolving
locus with vastly different gene repertoires in different
mammalian species and even within mouse strains.
Phylogenetic analysis shows a clear distinction between
AIM2 and other family members, suggesting divergence
in function. Surprisingly, given the important role for
AIM2 in host defence in mouse, AIM2 appears only as a
pseudogene in a number of different lineages, and
appears to have been lost from genomes on several inde-
pendent occasions during evolution.
Results and Discussion
The PYHIN Gene Locus in Mouse
The PYHIN gene cluster is found in a syntenic region in
many mammals, located between the Cell Adhesion Mol-
ecule 3 (CADM3) gene and a collection of olfactory
receptors and spectrin alpha chain (SPTA1), on chromo-
some 1q band H3 in mouse, 1q23 in human, and 13q24
in rat (Figure 1). On the basis of predicted genes and
cDNA sequences, we PCR-cloned the open reading
frames of 12 factors mapping to the locus from C57BL/6
splenic cDNA (Ifi203-205, 207–214) (Table 1, Figure 1)
or cDNA from RAW264 cell line (Ifi202) and obtained
cDNA for Ifi206 from Ricky Johnstone (PeterMacCallum Cancer Centre, Melbourne). A fourteenth
predicted gene [MGI: Gm16340] can be discerned but
there is only sparse EST evidence supporting its expres-
sion, compared with other genes. It encodes an intact
open reading frame, and differs from Ifi203 in only 25
amino acids out of 410, hence we have here termed it
Ifi203´. The gene denoted here Ifi207, identified by
Ludlow et al. [22] appears identical with Ifi201, for
which a partial genomic DNA sequence had been pub-
lished [21]. Although our cloned cDNA for Ifi208
encodes a protein without a HIN domain, there is a HIN
domain encoded by DNA immediately downstream of
Ifi208 (Figure 1), which is represented in EST databases.
Thus a HIN-containing splice variant of Ifi208 may
exist.
Divergence of the locus between mouse strains
The PYHIN gene locus is divergent in different mouse
strains. The region encoding Mndal/Ifi212 is absent in a
number of related mouse strains including DBA/2J,
AKR/N, and NZB/BINJ [28]. Part of Ifi203 is also miss-
ing in DBA [28], explaining the lack of Ifi203 mRNA in
that strain [59]. Zhang et al. [28] presented an arrange-
ment of genes in the locus generated from two overlap-
ping BAC sequences, one from C57BL/6 and one from
129X1/SvJ. This presents a model not consistent with
the current C57BL/6 genome, and suggests that the 129
strain may be missing the genes Ifi211 and Ifi203 which lie
between Mndal/Ifi212 and Ifi202 in C57BL/6 (Figure 1).
In contradiction to this, an earlier map of the 129 strain
mouse locus showed two extra duplications of Ifi203 [20],
one of which may be Ifi203´ (Gm16340). In addition,
there are two Ifi202 genes and a pseudogene in the 129
mouse genome, designated Ifi202a, b and c [20,60], but
only one Ifi202 gene in C57BL/6 (Figure 1), which has a
number of minor sequence variations from the pub-
lished Ifi202a and b [60]. Thus it seems that in the
mouse lineage, the PYHIN locus has been subject to fre-
quent amplification and rearrangement.
Human and rat PYHIN loci
The human locus is simpler, with 4 identified genes
(AIM2, IFI16, IFIX, MNDA, Figure 1). The human AIM2
gene, like mouse Aim2, lies in the reverse orientation to
other genes at one end of the gene cluster near the
CADM3 gene. Interestingly, the human locus may also
be prone to duplications, as a recent paper reports copy-
number variation, including within the IFI16 gene, in
the human population [61]. The rat genome is incom-
plete, with gaps remaining within the locus. There are
currently four identifiable genes with both pyrin and
HIN domains (Aim2 and Rhin2-4) and an isolated pyrin
domain (Rhin5) (Figure 1). EST databases support the
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Figure 1 Maps of the human, C57BL/6 mouse and rat PYHIN gene loci, based on NCBI human v36.3, mouse MGSCv37.2 and rat
RGSCv3.4 assemblies. The boundaries of the gene cluster in all three species are defined by the CADM3 gene and an olfactory receptor gene
cluster. A number of bridged gaps are present in the rat locus, denoted by white boxes. The asterisk on the mouse locus denotes a HIN domain
sequence, with expression supported by EST data. Accession numbers and alternative names for genes are provided in Table 1.
Table 1 Mouse, human and rat PYHIN gene accession numbers and nomenclature. Mouse sequences are from C57BL/6
Species Name Gene ID Gene Symbol Genbank Accession Other Names
Human IFI16 3428 IFI16 NM_005531.2 PYHIN2
IFIX 149628 PYHIN1 NM_198929.4
MNDA 4332 MNDA NM_002432.1 PYHIN3
AIM2 9447 AIM2 NM_004833.1 PYHIN4
Mouse Ifi202 26388 Ifi202 NM_0119140.2
Ifi203 15950 Ifi203 NM_008328.2
Ifi203’ 100504283 Gm16340 XM_003084464.1
Ifi204 15951 Ifi204 NM_008329.2
Ifi205 226695 Ifi205 NM_172648 D3', Ifi205a
Ifi206 240921 Gm4955 XM_136331.8
Ifi207 226691 AI607873 NM_001204910.1
Ifi208 100033459 Pydc3 NM_001162938.1
Ifi209 236312 Pyhin1 NM_175026.2 Ifix
Aim2/Ifi210 383619 Aim2 NM_001013779.2
Ifi211 381308 Mnda NM_001033450.3 D3, Ifi205b, Pyhin3
Mndal/Ifi212 100040462 Mndal NM_001170853.1
Ifi213 623121 Pydc4 NM_001177349.1
Ifi214 - - JN200820.1
Rat Aim2 304987 Aim2 XM_222949.5 Rhin1
Rhin2 289245 RGD1562462 XR_086006.1
Rhin3 304988 Ifi204 NP_001012029.1 Mnda, rHin-3
Rhin4 498288 Ifi203-ps1 XR_086004.1 Ifi203
Rhin5 689152 LOC689152 XM_002728037.1
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PYHIN gene and protein nomenclature has been con-
fused over the years due to the similarity between genes.
Early papers on a family member termed D3 [62] show
sequence from the Ifi211 gene, although this name also
seems to have been used for the Ifi205 gene, which is
very similar. What we have termed Ifi211 here has been
annotated as Ifi205b in a recent review [30]. However,
the N-terminal 200 amino acids encoded by Ifi211 are
more closely related to Ifi204 (98% amino acid identity),
perhaps indicating recent gene conversion (Additional
file 1: Figure S1). Consequently, we favour independent
names for these genes. New names for genes have also
been introduced during genome annotation on the basis
of some inter-species sequence similarities. We show
later in this paper that apart from AIM2 there are no
direct orthologues between mouse and human. Thus, we
propose the simple numbering for mouse genes indi-
cated in Table 1.
The mouse, human and rat protein families
The domain organisation inferred from cDNA sequences
reveals that whilst most proteins have a pyrin domain at
the N terminus and a C-terminal HIN domain, there are
also cDNAs coding for proteins with no pyrin domain


































































Figure 2 Predicted protein domain organisation derived from cDNA s
Pyrin domains are indicated by stippled boxes, and the HIN domain subtyp
human IFI16 and IFIX, with complete details summarised previously [22]. M
similarity among mouse proteins and the relationship between mouse andno HIN domains (p208, p213, AIM2b) (Figure 2). A
number of splice variants exist for IFI16, IFIX and Ifi203,
detailed elsewhere [22,63]. We have identified a splice
variant of mouse Aim2 that would generate a pyrin-only
protein, termed here AIM2b (Genbank JQ894737).
Identification of PYHIN genes in a range of species
Rigorous TBLASTN and iterative PSI-BLAST searches
for PYHIN proteins in vertebrates revealed no trace of
HIN domains outside of mammals, nor any other closely
related domains. Although structural evidence suggests
the HIN domain may have evolved from a DNA-binding
OB-fold [55], there is now little primary sequence hom-
ology between HIN and other DNA-binding domains.
PYHIN pyrin domains have some sequence similarity to
pyrin domains found in NOD-like receptor proteins.
Our searches in non-mammals using PYHIN pyrin
domains returned only domains from these other pro-
tein families. TBLASTN searches in marsupials found
only a single PYHIN coding sequence in each of opos-
sum, Tasmanian devil and wallaby. Thus, at least one
PYHIN gene existed prior to the divergence of marsu-
pials and placental mammals. There is no evidence of
any such gene in the platypus genome (NCBI Build 1.1,
6-fold coverage). Whether this truly reflects an absence


































equences for human and mouse and predicted genes for rat.
es (A, B or C) are shown. Only a single splice variant is shown for
ouse p203 also has known splice variants [63]. Regions of sequence
rat proteins are summarised in Additional Files 1 and 6.
Cridland et al. BMC Evolutionary Biology 2012, 12:140 Page 6 of 17
http://www.biomedcentral.com/1471-2148/12/140remains to be established. PYHIN gene sequences were
identified in all major groups of mammals, except bats.Phylogenetic analysis supports HIN domain subtypes
To examine the evolution of the gene cluster during
mammalian radiation, we used sequences from species
in each of the major clades on the mammalian species
tree (Table 1 and Additional File 2: Table S1). Evident
shuffling of pyrin and HIN domain coding sequences be-
tween genes in mouse and in other species, as well as
highly variable sequences in the region between pyrin
and HIN domains meant that phylogenetic analyses of
the protein sequences as a whole were not informative.
Consequently, pyrin and HIN domains were used separ-
ately for analysis, with alignments of these domains pro-
vided in Additional File 3: Figure S3 and Additional



































































Figure 3 Bayesian phylogenetic tree of HIN domains from a range of
sequences. Posterior probabilities ≥0.7 in this analysis are shown above th
likelihood-ratio test values >0.85, except as indicated) are shown by dots o
likelihood-ratio test values are shown as a number below the node. Dotted
marsupial HIN-D. Sequences used are specified in Table 1 and Additional F
S3.all the available complete (two-exon) HIN domain
sequences.
Trees were generated by Bayesian as well as maximum
likelihood approaches. A HIN domain phylogenetic tree
derived from Bayesian analysis is shown in Figure 3,
rooted with marsupial sequences. Overall, the tree top-
ology was very similar by the two methods as indicated
in Figure 3. This revealed three distinct clades of placen-
tal mammal sequences, consistent with previous assign-
ment of HIN-A, HIN-B and HIN-C type domains [22].
The marsupial sequences cluster separately, and we have
termed these HIN-D. The HIN-C domain is uniquely
found in AIM2-like sequences, present at a maximum of
one copy in each genome. A clear difference in the role
of HIN-A, -B, and -C domains is yet to be established,
although recombinantly expressed IFI16 HIN-A and
HIN-B domains differ in their ability to bind DNA [13].











































placental and marsupial mammals rooted with marsupial
e nodes. Clades that were supported by PhyML analysis (with
n the nodes. For a limited number of important nodes the PhyML
lines separate observable HIN clades: placental HIN-A, -B, and -C, and
ile 2: Table S2, and the alignment is shown in Additional File 3: Figure
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may recognise different structures or sequences of DNA,
and consequently be optimal for recognition of distinct
classes of pathogens. Notable from this analysis is the
branch length for mouse p202 HIN domains, particularly
the HIN-B domain, indicating a rapid divergence from
other mouse HIN domains.
Pyrin domain phylogeny shows the distinct nature of
AIM2
Similar approaches were taken to generate phylogenetic
trees for PYHIN pyrin domains, rooted with marsupial
sequences. The resolution of these trees was limited by
the short sequence of the pyrin domain (88 amino
acids). However, the majority of clades were predicted
similarly by Bayesian and maximum likelihood methods,






























Figure 4 Bayesian phylogenetic tree of PYHIN pyrin domains across p
sequences. Where a pyrin domain is clearly from the same gene as a HIN
domains from low coverage genomes cannot definitively be linked to part
Posterior probabilities >0.7 are shown above nodes. Clades which were sup
shown by dots on the nodes. For a limited number of important nodes the
node. Dotted lines indicate the three distinct clades: marsupial pyrin, pyrin
placental non-AIM2 (IFI) sequences. Sequences used are defined in Table 1
Figure S4.demonstration of two markedly separate clades amongst
the placental mammal proteins, one containing AIM2
orthologues, and another encompassing all other (“IFI”)
PYHINs (Figure 4). The large divergence between the
AIM2 and IFI sequences is evident by the long branch
lengths separating these clades.
The maintenance of such a distinct pyrin domain in
AIM2 suggests it has a different role from that of the
other PYHIN proteins. Divergence of AIM2 and IFI
pyrin domains occurred prior to placental mammal spe-
ciation, since diverse mammalian species have main-
tained distinct AIM2 and IFI pyrin sequences. In AIM2,
the HIN domain binds DNA and the pyrin domain
recruits ASC and nucleates the formation of the DNA
inflammasome. Earlier results suggested that the AIM2
pyrin domain, but not other human PYHIN factors,









































































lacental and marsupial mammals, rooted with marsupial
domain, labels are the same as Figure 3 (e.g. Cow 1). Some pyrin
icular HIN domains, and are indicated with letters (e.g. Hyrax a).
ported by PhyML analysis with likelihood-ratio test values >0.74 are
PhyML likelihood-ratio test values are shown as a number below the
domains from placental AIM2 sequences, and pyrin domains from
and Additional File 2: Table S1, and alignment in Additional File 4:
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http://www.biomedcentral.com/1471-2148/12/140binds viral DNA in the nucleus and initiates inflamma-
some responses [12], although a direct interaction with
ASC has not been demonstrated. Further work to exam-
ine proteins interacting with the IFI pyrin domains is
warranted.
Amongst the non-AIM2 sequences, the pyrin tree top-
ology (Figure 4) is markedly different from the HIN tree
(Figure 3). There is no distinction between the pyrin
domains of HIN-A and HIN-B containing proteins. In
some cases, there has been evident gene conversion or
domain shuffling which has maintained similarity of
pyrin domain sequences within a species. For example,
the two dog pyrin sequences are closely related, although
one dog gene contains a HIN-A and one a HIN-B.
Multiple species have AIM2 pseudogenes
AIM2 is required for optimal defence against some viral
and bacterial pathogens in mouse [6,7]. In contrast to
the variable expansions of the other PYHIN family mem-
bers, we have observed AIM2 in only one copy per gen-
ome. Surprisingly, we found no intact AIM2, but
evidence for an AIM2 pseudogene in cow, llama, dolphin
and sheep (Figure 5, Additional File 5: Figure S5) as well
as elephant and dog (not shown). These sequences all
encode HIN-C, more similar to AIM2 than other human





























Figure 5 Presence and absence of HIN domains in individual species,
HIN domains indicated must be considered a minimum estimate of the tru
fold sequence coverage (dolphin, sloth, armadillo, hyrax and wallaby). The
domains is indicated. Putative points of loss of a functional AIM2 HIN-C do
number of species, and likely absence of a gene in pig. Independent loss o
the phylogenetic relationship between horse, dog and Cetartiodactyla [65]
exon is available, this sequence was not used in phylogenetic analysis. Dup
are not indicated on the species branches here.frame shifts and/or multiple stop codons. Cow, llama,
dolphin and sheep are all part of the Cetartiodactyla
[64], and there may have been basal loss of AIM2 in the
evolution of this clade (Figure 5). Pig also falls within
this group, and we could find no discernible AIM2 gene
or pseudogene sequence within the available pig genome
(Ensembl Sscrofa9), which has four-fold coverage. Horse
appears to have an intact AIM2 gene, whilst dog has a
pseudogene. The phylogenetic relationship between
horse, dog and the Cetartiodactyla is controversial [65],
and an independent origin for the dog pseudogene, as
shown in Figure 5, cannot be confirmed. However, gen-
eration of the elephant pseudogene must have been an
independent event (Figure 5). It cannot be excluded that
further sequencing may reveal intact AIM2 in some of
these species. However, the neighbouring CADM3 gene
can be reliably identified in the published genomes of all
these species except sheep, which has relatively low
coverage. Although AIM2 is of demonstrated import-
ance in mouse [6,7], the probable loss of AIM2 in some
species suggests they have evolved alternate mechanisms
to cope with DNA viruses and intracellular bacteria.
Lineage-specific gene family expansions
There are variable expansions of HIN-A and HIN-B en-
























































































mapped onto a mammalian species tree [64,67]. The number of
e number of HIN domains, particularly for the genomes with only 2-
duplication of the ancestral gene to generate HIN-A, -B, and -C
main are marked, consistent with the presence of pseudogenes in a
f AIM2 in dog as indicated, cannot be confirmed due to uncertainty in
. Armadillo has evidence for an Aim2 HIN-C sequence, but as only one
lications and losses of HIN-A and HIN-B domains are numerous and
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mouse genes appear to have arisen by duplication after
separation from the rat lineage (Figures 3 and 4). Be-
tween one and four mouse genes are co-orthologous to
each of the five rat genes. Rhin2 is orthologous to Ifi206
(Figures 3 and 4) and is conserved in location in the
locus adjacent to Aim2 (Figure 1). Rhin3 and Rhin4 are
orthologous to clusters of mouse HIN-A and HIN-B
containing genes respectively. Rhin5 is lacking a HIN
domain coding sequence, but is otherwise orthologous
to Ifi214 and Ifi209. The relationship between mouse
and rat proteins is summarised in Additional File 6:
Figure S2. Apart from gene duplication in the mouse,
there has been some domain swapping between paralo-
gues and this provides a patchwork of sequence simi-
larity between different proteins. For example, p212 is
a hybrid between p203 and p205-like sequences
[28,66]. The regions of sequence similarity between
different mouse proteins are summarised in Additional
File 1: Figure S1.
Lineage-specific duplications are also evident within
horse, which has 6 recognisable genes, four of which
form a clade on the pyrin tree (Figure 4). In contrast,
the cow genome (UMD3.1 assembly) shows only a single
intact PYHIN gene. The specific expansion of the gene
family in some species may reflect the evolutionary
“arms race” involved in combating infections. Gene du-
plication and diversification may allow better control of
lineage-specific pathogens.
Evolution of the PYHIN family
To describe the evolution of the PYHIN family, the HIN
domain tree was reconciled with a mammalian species
tree (Figure 5 [64,67]). Duplication and deletion events
were inferred based on the presence or absence of HIN
domains and pseudogenes in different species. The
model proposes that an ancestral HIN domain was amp-
lified after the divergence of placental mammals and
marsupials, and evolved into HIN-A, -B, and -C in the
ancestor of all placental mammals (Figure 5). We found
evidence for sequences for HIN-A, HIN-B and HIN-C
domains within the Afrotheria (elephant and hyrax) and
Xenarthra (armadillo and sloth), which are the most
basal groups of placental mammals (Figures 3 and 5).
The losses of the unique AIM2 HIN-C domain described
above are indicated in Figure 5. Some species show nu-
merous pseudogenes containing HIN-A and HIN-B
domains, but these are not considered here. The final
number and composition of PYHIN proteins differs
greatly between species, although dolphin, armadillo,
sloth and hyrax genomes have been sequenced only at
low coverage, and the genes indicated are likely a mini-
mum estimate of the true number of genes in these
species.Branch lengths for both HIN and pyrin trees predict
that AIM2 is somewhat closer in sequence to the PYHIN
gene in the last common ancestor of placental mammals
and marsupials, than are the other IFI sequences
(Figures 3 and 4). This is most pronounced for the
pyrin domain sequences (Figure 4). It is reasonable to
propose that the ancestral function of the gene was
similar to AIM2, in nucleating the inflammasome
through recruitment of ASC. This function for the
ancestral PYHIN would be expected, since ASC bind-
ing is a function also conserved in more distant pyrin
domain-containing proteins such as NLRP3.
Orthology between mouse and human
The identification of mouse and human orthologues is
relevant to the use of mouse models for the study of
human cellular processes and disease. Human and
mouse AIM2 were the only direct orthologues identified
between these species based on the phylogenetic ana-
lyses of both HIN and pyrin domains (Figures 3 and 4).
The human IFI16 and IFIX proteins result from gene
duplication within the primate lineage. The HIN-A
domains of these proteins also cluster with higher prob-
ability with human and chimpanzee MNDA than with
the clade of rodent HIN-A domains. This is consistent
with speciation of rodent and primate lineages prior to
amplification of the HIN-A domain. The C-terminal
HIN domain in IFI16 is the sole human HIN-B domain.
Rodent HIN-B domains are all more similar to one an-
other than they are to the human. Thus there are no dir-
ect mouse orthologues of human IFI16, IFIX or MNDA.
However, the pyrin domain tree shows that mouse p204,
p211, p205 and p207 form a clade with human IFI16
and IFIX, rather than with other mouse proteins. If there
is any functional distinction between the IFI pyrin do-
main clades, then these mouse proteins might have the
closest effector function to IFI16 and IFIX.
Whilst it is tempting to infer common ancestry on the
basis of shared arrangements of domains (i.e. IFI16 looks
like p204), it is most likely that the acquisition of the
double HIN domain structure in IFI16 and p204 arose
by independent events, as there is no evidence for tan-
dem HIN domains in any other non-primate species, in-
cluding rat, and the phylogenetic analyses of HIN
domain sequences did not support them as being ortho-
logous. Despite the lack of 1:1 orthology between mouse
and human in the non-AIM2 proteins, they may all be
functionally quite similar. Gene duplications within a
species could permit the evolution of different expres-
sion patterns or different intracellular locations, or may
contain amino acid changes that circumvent the efforts
of pathogens to evade detection. Gene expression pat-
terns were investigated, to see whether the gene amplifi-
cation had generated differential expression patterns.
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Mouse AIM2 expression analysed by northern blot,
showed predominant expression of AIM2 mRNA in
spleen and large intestine (Figure 6). Real-time PCR
generated a similar pattern of expression (Figure 7a).
Previous work on human AIM2 found expression pre-
dominantly in spleen, with detectable mRNA in small
intestine and peripheral blood but levels below detec-
tion in most other tissues tested [25]. Primers were
designed for real-time PCR of all mouse family mem-
bers, and tested for off-target amplification using
cloned cDNAs from all mouse PYHIN genes. We were
unable to design primers to specifically amplify Ifi211,
due to its near identity to Ifi204 at the 5´ end, and
high similarity to Ifi205, 204 and 212 in the rest of the
gene. Screening of mouse tissues showed a variety of
expression patterns. Spleen was a major site for most
but not all factors. Tissues were obtained from C57BL/
6 mice, which unlike other strains express negligible
amounts of Ifi202 mRNA in spleen [68]. However,
C57BL/6 skin showed detectable Ifi202 expression.
Ifi205, 204 and 207 showed strongest expression in
skin, and interestingly these form a clade on the pyrin tree,
together with Ifi211 (Figure 4), for which we could not ana-
lyse expression. This group forms a larger clade with the
pyrin domains of human IFIX and IFI16 (Figure 4). Apart
from hematopoietic cell expression, IFI16 is expressed in
epithelial cells and vascular endothelial cells [69-71]. It is
prominently expressed in the lower proliferating layers of
epithelia, including the skin [69]. Defence of proliferating
keratinocytes against infection is a likely role for this group
of skin-expressed human and mouse proteins.
Ifi204 was also well expressed in liver, heart and skel-







































Figure 6 Northern blots for Aim2 expression in C57BL/6 mouse tissue
three mouse strains. Results for 18 S rRNA are shown as a loading contro
contamination. Results are representative of two independent tissue samplmuscle differentiation [39]. One paper has suggested
that Ifi203 expression at mRNA and protein level is lim-
ited to the liver [63], although we and others find it
more widely expressed, with strongest expression in the
spleen [28]. Overall, our results agree very well with
those obtained for expression of Ifi203-205 and Mndal/
Ifi212 in BALB/c mouse tissues by Zhang et al. [28], and
provide data for an extra seven genes.
PYHIN genes have been predominantly studied in
hematopoietic cells, and here we have compared expres-
sion of the twelve genes in splenic T and B cells, as
well as in bone marrow-derived macrophages (BMM)
and thioglycollate-elicited peritoneal macrophages
(Figure 7b). Aim2 was readily detectable in all cells.
Some genes such as Ifi203, 206 and 213 were expressed
well except in elicited macrophages. Ifi204, in contrast,
was relatively myeloid restricted amongst the immune
cell types, but is not restricted to myeloid cells since it
had highest expression in skin (Figure 7a). The duplica-
tion of PYHIN genes allows for evolution of distinct pat-
terns of regulation of similar genes. An example of this
is seen with Ifi209 and Ifi214, which result from recent
duplication. Although on a tissue level they were simi-
larly spleen-specific, on a cellular level Ifi209 was
expressed in T, B and BMM, whereas Ifi214 was T and B
cell-specific.
Lastly, we examined expression in BMM from three
different mouse strains (Figure 7c). Ifi202 showed
marked differential expression, in agreement with previ-
ous work [4,68,72], and has been investigated as a pos-
sible susceptibility factor for lupus in the NZB mouse
strain [41]. The lack of expression of Mndal/Ifi212 in
NZB is due to the lack of this gene in DBA and related
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Figure 7 Expression of mouse PYHIN genes in perfused C57BL/6 mouse tissues (a), in various C57BL/6 mouse immune cells – splenic T
and B cells, BMM and thioglycollate elicited peritoneal macrophages (TEPM) (b), and in BMM from three different mouse strains (c).
Real time PCR results for each gene were normalised to the average of four housekeeping genes, which was found to give a relatively stable
signal between tissues. Primers were tested to ensure lack of significant amplification of non-target PYHIN cDNAs. Results shown are the mean
and range derived from duplicate RNA preparations.
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http://www.biomedcentral.com/1471-2148/12/140and Ifi213, and minimal expression detected for Ifi208 in
both NZB and BALB/c BMM. Interestingly, these genes
are all clustered at one end of the gene array, near Aim2
(Figure 1). This suggests that this region may be lacking
in these strains. Strain-specific data are not shown for
Ifi214, since this gene is barely expressed in BMM
(Figure 7b).
The inter-strain differences complicate analysis of the
AIM2 gene trap knockout mice [6,7]. The gene trap al-
lele is derived from 129 mouse ES cells and is generally
used on a mixed 129 and C57BL/6 background. In the
knockout mice, the PYHIN locus and chromosome 1
regions surrounding the null AIM2 allele will derive only
from 129 mice, whereas littermate controls with intact
AIM2 will carry the C57BL/6 gene array. Use of AIM2
knockout mice on a pure background will thus be essen-
tial for many studies of AIM2 function in disease.
In summary, spleen and skin were the two most prom-
inent sites of mouse PYHIN expression, consistent with
a role in immune defence. Gene family expansion in
mouse has allowed some diversification of expression
patterns. Human and mouse PYHIN genes are variously
expressed in a range of immune cell types and also epi-
thelial and endothelial cells, although the genes do not
obviously fill identical “niches”. For example MNDA is
strongly myeloid restricted [73,74], but there seems to
be no similarly expressed mouse gene. Apart from
AIM2, the lack of concordance of expression patterns
and sequence between mouse and human genes empha-
sises the need to consider the roles of individual proteins
separately in the two species.
Conclusions
Defences against invading DNA are likely to be found
within all species, and are of course well characterised in
the bacterial restriction/modification systems. The evo-
lution of the first PYHIN protein is likely to have pro-
vided a new effector system for combating the threats
indicated by stray DNA within mammalian cells. AIM2
appears less changed from the ancestral protein than are
the other PYHIN proteins, and we anticipate the ances-
tral protein functioned similarly, in recruitment of the
inflammasome in response to cytosolic DNA. A role for
combating infectious threats is established for AIM2
[6,7], with both cytokine production and cell death likely
to be important PYHIN-mediated defences. Duplication
of the ancestral gene in the placental mammals may
have enabled defence against organisms with a range of
different replicative and evasion strategies. Since the
HIN domain is the DNA-binding domain, the evolution
of HIN-A, -B, and -C subtypes in placental mammals
may have allowed specialisation to recognise different
DNA structures. Differences in DNA-binding prefer-
ences of these domains are yet to be established. Thepyrin domain evolution is constrained by maintenance
of protein-protein interactions, such as recruitment of
ASC for the AIM2 pyrin. Differences in interaction part-
ners between AIM2 and the other PYHIN proteins war-
rants investigation, given the distinct natures of their
pyrin domains. Further gene expansions prominent in
mouse and horse may have provided particular advan-
tage in combating species-specific infections. However, it
is also possible that a driving force in evolution of the
gene family is defence against high activity of endogen-
ous retroelements, which create reverse transcribed
DNA. Although evolution has been fuelled by waves of
activity of retroelements [75], levels of activity need to
be controlled to prevent excessive genome damage
within each generation, and within somatic cells. Retroe-
lements are generally silenced by methylation, and there
is increasing evidence for their role in cancer and auto-
immunity [76,77]. Cell death, as is mediated by AIM2 in
response to cytosolic DNA, may be an appropriate re-
sponse to eliminate cells where retroelements are in-
appropriately active. Interestingly, the estimated ages of
retroelements in human and mouse genomes show on-
going high activity in the mouse genome but not human
genome [78]. Thus it is conceivable that PYHIN expan-
sion in the mouse could be driven by a need to control
retroelement activity, as well as infectious disease.
Methods
cDNA cloning of mouse PYHIN family
To find novel PYHIN family coding sequences, DNA se-
quence based on the Pfam Pyrin domain was used to
screen the NCBI Riken Transcripts Database. The NCBI
databases and Ensembl genome browser also provided
predicted genes in the PYHIN locus. Primers were
designed to amplify complete coding sequences of pub-
lished and novel mouse PYHIN genes, and PCR reac-
tions were performed on cDNA from C57BL/6 mouse
spleen and cloned into pEF6-TOPO-TA vector
(Invitrogen).
Genome searches for PYHIN family members
To assess the range of species in which PYHIN proteins
could be discerned, TBLASTN searches were conducted
against the GenBank whole-genome shotgun sequence
database, using human AIM2 and IFI16 protein
sequences and an expect threshold (E) of 10. From this a
number of genomes spanning major placental mammal
lineages, as well as all three available marsupial genes
were selected for comprehensive analysis of PYHIN
genes. Genomes analysed were: human (Homo sapiens
NCBI v36.3), mouse (Mus musculus MGSCv37.2), rat
(Rattus norvegicus RGSCv3.4), horse (Equus caballus
EquCab2), dog (Canis lupus familiaris CanFam2.0), cow
(Bos taurus UMD3.1), pig (Sus scrofa ENS:Sscrofa9),
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(Loxodonta Africana loxAfr3), dolphin (Tursiops trun-
cates turTru1), hyrax (Procavia capensis proCap1), sloth
(Choloepus hoffmanni choHof1), armadillo (Dasypus
novemcinctus dasNov2), opossum (Monodelphis domes-
tica MonDom5), wallaby (Macropus eugenii Meug_1.0),
and Tasmanian devil (Sarcophilus harrisii DEVIL7.0).
Ensembl and NCBI genomic sequence databases were
searched using TBLASTN and individual pyrin and HIN
domain amino acid sequences from human AIM2 and
IFI16, using default settings, and also with the gap open-
ing penalty reduced to −9 and the expect threshold
increased to 10. Genomes were also searched using a
predicted protein from within the same genome to de-
tect potential paralogs not detected by searching with
human AIM2 or IFI16. The rat, opossum, dog and horse
genomes were also searched using HIN and pyrin do-
main motifs using the MEME [79] and MAST v4.3.0
[80] software suite. Motifs that crossed different exons
of the HIN domain were avoided. The motifs were used
to search Ensembl ab initio predicted proteins. When
novel unannotated genes were detected, genomic
sequences containing PYHIN genes were examined for
potential splice sites in conserved positions, and exons
encoding a pyrin domain or the two exons encoding the
HIN domain were extracted.
Analysis of platypus and non-mammalian genomes
The platypus genome (Ornithorhynchus anatinus Build
1.1) was searched using TBLASTN for the full-length
predicted PYHIN protein from opossum and full-length
human IFI16. In another approach, all HIN domains
identified in the 6x coverage mammalian genomes were
used to build a profile hidden Markov model with the
software HMMER [81], which was then used to screen
the platypus ab initio peptide predictions available from
Ensembl. An inferred ancestral HIN domain sequence
from the node that predates the split between HIN-A,
-B and -C domains was also used to perform this search.
The genomes of chicken (Gallus gallus release 2.1), frog
(Xenopus tropicalis version 4.1), anole lizard (Anolis car-
olinensis AnoCar1.0) and zebrafish (Danio rerio Zv8),
available via NCBI and Ensembl, were searched using
TBLASTN with the HIN domain from opossum, and
human AIM2 and IFI16. None of these searches, nor the
general search of all shotgun genomic sequences, yielded
any trace of PYHIN genes in monotremes or non-
mammals.
Phylogenetic analyses
Phylogenetic analyses were performed separately on
pyrin and HIN domains. The linking region between
these domains was not used in the alignments as it is
highly variable between individual proteins, and it wasnot possible to identify this region in the low coverage
genomes. Alignments were constructed using ClustalW2
[82,83].
Phylogenetic inference was performed using Bayesian
and maximum-likelihood approaches. For Bayesian ana-
lyses we used MrBayes v3.1.2 [84], running 2 million
generations and 4 chains for each analysis, setting a
burn-in of 2500 samples and sampling the tree space
every 100 generations. Model jumping between fixed-
rate amino acid models was used to determine the most-
suitable substitution model, otherwise using default
parameters. All analyses favoured the Jones substitution
model [85]. Convergence was judged using the standard
deviation of split frequencies and the plot of log likeli-
hoods. Rooted trees were drawn using Mesquite v2.6
[86].
Maximum-likelihood analyses were performed using
PhyML 3.0 [87] under the LG substitution model [88]
with 4 substitution rate categories. The proportion of in-
variable sites and the gamma shape parameter were esti-
mated from the data. We used 10 random starting trees,
and subtree pruning and regrafting (SPR) [89] to search
tree space. Both tree topology and branch lengths were
optimized to maximize the likelihood. Branch support
was estimated using 100 bootstrap replicates, and by cal-
culating an approximate likelihood-ratio test [90].
Isolation of mouse splenic immune cells
Mice were used as a source of tissues, under approval
from the University of Queensland animal ethics com-
mittee (Approval number IMB/874/08). Splenocytes
from C57BL/6 mice were harvested by homogenization
of mouse spleens and red blood cells lysed by standard
Gey’s solution procedure. CD19+ B cells and CD90.2+ T
cells were isolated by positive selection using MACS
microbeads, run according to manufacturer’s instruc-
tions (Miltenyi Biotec) over multiple columns. The pur-
ity of B and T cells assessed by flow cytometry was
>98%. Bone marrow-derived macrophages from BALB/c,
C57BL/6 or NZB mice were derived and cultured as
described [91]. NZB mice were supplied by Kew animal
house (Walter and Eliza Hall Institute, Australia), BALB/c
by Animal Resources Centre, Perth, and C57BL/6 by Uni-
versity of Queensland Biological Resources. Thioglycollate
elicited peritoneal macrophages were harvested from
C57BL/6 mice and cultured as described [92].
RNA isolation and real-time PCR
RNeasy Total RNA isolation kits (QIAGEN) were used
to isolate RNA from mouse cell preparations, as well as
from perfused C57BL/6 mouse tissues, according to
standard protocols (QIAGEN). All tissues except bone
marrow, spleen, liver, kidney and brain included a Pro-
teinase K digestion step. cDNA was synthesised as
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variants of mouse PYHIN mRNAs, primers were
designed to detect all variants (Additional File 7: Table
S2). Efficiency of amplification was checked for the tar-
get gene. Specificity of each of the mouse PYHIN primer
sets was assessed by running qPCR using a standard
amount of each of the various different cloned PYHIN
cDNAs as templates. Specificity was considered to be
adequate when amplification of the target gene was
achieved more than 10–12 cycles ahead of any other
gene. Appropriate specificity was not achieved for Ifi211,
and it could not be analysed here. Primers for Ifi209 also
amplified Ifi214. However, primers for Ifi214 were spe-
cific and samples had a low level of Ifi214, which had
minimal effect on the Ifi209 expression data.
Levels of gene expression are shown for the test gene
relative to the average expression of four house-keeping
genes (Tbp, Hprt, Cxxc1, Rpl13A), performed in dupli-
cate. These were quantified by RT PCR using the ΔCT
method [94] as described [4]. Single exon primers were
also tested against reactions containing no reverse tran-
scriptase to ensure no genomic DNA contamination.
Northern Blotting
10 μg of tissue RNAs and 7.5 μg of immune cell RNAs
were resolved on a 1% MOPS/formaldehyde gel. The
RNA was transferred to a Zeta-probe membrane
(BioRad) by capillary blotting, and hybridised with AIM2
coding region cDNA probe at 65 °C or an oligonucleo-
tide probe to 18 S rRNA at 42 °C according to manufac-
turer’s protocols (Biorad). The AIM2 probe was labelled
as per the Amersham MegaPrime DNA Labelling Sys-
tem (GE Healthcare), and the 18 S rRNA probe was
labelled using γ32P-ATP and polynucleotide kinase.
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Additional file 1: Figure S1. Diagram of subsequence composition of
mouse PYHIN proteins.
Additional file 2: Table S1. Sources of sequence data for PYHIN
proteins from animals other than mouse, rat and human.
Additional file 3: Figure S3. HIN domain alignment.
Additional file 4: Figure S4. Pyrin domain alignment.
Additional file 5: Figure S5. Evidence for cow, dolphin, llama and
sheep AIM2 pseudogenes.
Additional file 6: Figure S2. Comparison of mouse and rat PYHIN
proteins.
Additional file 7: Table S2. Sequences of primers for real time PCR.
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